The funding will help Ada Health double down on its largest market, the US. Here are the top-line bullets you need to know.
Ada Health, a digital medical assessment platform, has raised $90M in a Series B. The round drew participation from Bayer, Samsung, Vitruvian Partners, and F4, among others.
HOW’S THE COMPANY PERFORMING?
- Berlin-based Ada Health is an AI-based digital health assessment platform that evaluates early symptoms, identifies health conditions, and offers medical guidance for booking appointments.
- The company states that the application serves over 11M users globally, with more than 23M assessments to date.
- Its customer base includes Axa OneHealth, Novartis, Pfizer, SutterHealth, and Takeda, among others.
- Ada Health has a team of 250 employees across Berlin, London, Munich, and New York.
Want the full post? Become a CB Insights customer.
If you’re already a customer, log in here.